Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 1 Dosing Study of BAX 513 in Healthy Volunteers

This study has been completed.
Information provided by:
Baxalta US Inc. Identifier:
First received: February 4, 2010
Last updated: June 26, 2015
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)